Masahiro Hatori

4PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Apr 29, 2024
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).

Masahiro Hatori, Daiki Tsuji, Kenichi Suzuki

|Sep 07, 2023
Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study.

Takashi Yokokawa, Kenichi Suzuki, Daiki Tsuji

|Oct 22, 2021
Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting.

Masahiro Hatori, Kazuyoshi Kawakami, Takeru Wakatsuki

Pageof 1

Frequent Collaborators

3 joint publications

Kazuyoshi Kawakami

3 joint publications

Takashi Yokokawa

3 joint publications

Daiki Tsuji

2 joint publications

Kazuo Kobayashi